Roger Pomerantz - 25 May 2023 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Roger Pomerantz
Issuer symbol
INDP
Transactions as of
25 May 2023
Net transactions value
$0
Form type
4
Filing time
30 May 2023, 16:15:38 UTC
Previous filing
28 Feb 2023
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 25 May 2023 Common Stock 30,000 $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable on May 25, 2024.